Asembia AXS 2026 Summit
The future of access and affordability is here at AXS26. Together with our biopharma partners, CoverMyMeds is advancing solutions that help drive faster, smarter decisions across the patient journey. See what we’re building next at Booth #1223.
From pioneering ePA and advancing fully automated prior authorizations, to creating an EHR-integrated platform that unifies medical and pharmacy benefit workflows, we’re built to keep therapies moving forward. The outcome? Proven access. Smarter systems. Trusted results. For therapies that can’t wait — and patients that shouldn’t have to.
Meet us at Booth #1223 to learn more.
Thursday, April 23, 2026, 1 p.m. ET
As the specialty pharmacy landscape rapidly changes, this CoverMyMeds Innovation Roundtable, held ahead of Asembia’s AXS26, will gather leaders from across biopharma services, access tech, policy and patient support to explore 2026 trends. Topics include AI in patient and provider support, collaborative approaches to access and affordability and the emerging forces shaping the specialty ecosystem.
An accomplished executive healthcare leader with over 15 years of experience in the industry, Miranda began her career as a registered nurse in hematology and oncology and quickly advanced to leadership roles. While serving as the Associate Director of Emergency Services at The Ohio State University Comprehensive Cancer Center, she and her team successfully launched the first fully integrated oncology emergency department in the United States. Since joining CoverMyMeds in 2017, she has successfully built and led high-performing clinical, operational and product teams. As the Vice President of Specialty Product, she has responsibility for improving the medication access journey for patients on specialty medications. Miranda holds a Doctor of Nursing Practice and is involved in a number of community and professional organizations including the Ronald McDonald House of Central Ohio, Nationwide Children’s Hospital Foundation, and Pelotonia.
Megan is a seasoned leader with over a decade of experience driving innovation in healthcare technology. Since joining McKesson in 2013, Megan has held various roles in product management, dedicating her career to supporting pharmacy and pharmaceutical customers. Most recently, she served as Vice President of Product for Hub Solutions, leading strategic product development to enhance patient access and affordability, building on her prior leadership of patient affordability solutions. Through her diverse experience, Megan continues to successfully lead teams in tackling complex challenges, particularly within the pharmaceutical industry. Based in Atlanta, Georgia, Megan is recognized for her strategic vision, collaborative leadership style and commitment to creating meaningful, scalable solutions that improve health outcomes.
Ashwin Singhania has over 20 years of experience in life sciences advising biopharma companies to support their strategic growth in bringing new products to market to enhance patient care. As a principal within Strategy and Transactions at EY-Parthenon, Ernst & Young LLP, Ashwin focuses on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. His career includes roles with large pharmaceutical organizations, specialty pharmaceuticals and prerevenue biotechs. He also supports private equity for investments in biopharmaceutical and biopharmaceutical services.
In her current leadership role, Fauzea champions public policy strategies that drive the company's mission to improve health outcomes. With a keen focus on patient-first solutions, Fauzea collaborates across the enterprise to address the diverse needs of distributors, wholesalers, community providers, health systems, pharmacies, manufacturers, technology vendors and consumers. A seasoned policy expert with over 25 years of experience, Fauzea has a proven track record in assessing the impact of state and federal policies on patient access, provider reimbursement, and the life sciences industry.
Nico Saraceno is the Senior Editor of Nutritional Outlook, a publication for the dietary supplement, healthy foods, and natural products market. He also has over a half-decade of experience covering pharma’s patient access and affordability space via his time with Pharmaceutical Commerce.
An accomplished executive healthcare leader with over 15 years of experience in the industry, Miranda began her career as a registered nurse in hematology and oncology and quickly advanced to leadership roles. While serving as the Associate Director of Emergency Services at The Ohio State University Comprehensive Cancer Center, she and her team successfully launched the first fully integrated oncology emergency department in the United States. Since joining CoverMyMeds in 2017, she has successfully built and led high-performing clinical, operational and product teams. As the Vice President of Specialty Product, she has responsibility for improving the medication access journey for patients on specialty medications. Miranda holds a Doctor of Nursing Practice and is involved in a number of community and professional organizations including the Ronald McDonald House of Central Ohio, Nationwide Children’s Hospital Foundation, and Pelotonia.
Megan is a seasoned leader with over a decade of experience driving innovation in healthcare technology. Since joining McKesson in 2013, Megan has held various roles in product management, dedicating her career to supporting pharmacy and pharmaceutical customers. Most recently, she served as Vice President of Product for Hub Solutions, leading strategic product development to enhance patient access and affordability, building on her prior leadership of patient affordability solutions. Through her diverse experience, Megan continues to successfully lead teams in tackling complex challenges, particularly within the pharmaceutical industry. Based in Atlanta, Georgia, Megan is recognized for her strategic vision, collaborative leadership style and commitment to creating meaningful, scalable solutions that improve health outcomes.
Ashwin Singhania has over 20 years of experience in life sciences advising biopharma companies to support their strategic growth in bringing new products to market to enhance patient care. As a principal within Strategy and Transactions at EY-Parthenon, Ernst & Young LLP, Ashwin focuses on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. His career includes roles with large pharmaceutical organizations, specialty pharmaceuticals and prerevenue biotechs. He also supports private equity for investments in biopharmaceutical and biopharmaceutical services.
In her current leadership role, Fauzea champions public policy strategies that drive the company's mission to improve health outcomes. With a keen focus on patient-first solutions, Fauzea collaborates across the enterprise to address the diverse needs of distributors, wholesalers, community providers, health systems, pharmacies, manufacturers, technology vendors and consumers. A seasoned policy expert with over 25 years of experience, Fauzea has a proven track record in assessing the impact of state and federal policies on patient access, provider reimbursement, and the life sciences industry.
Nico Saraceno is the Senior Editor of Nutritional Outlook, a publication for the dietary supplement, healthy foods, and natural products market. He also has over a half-decade of experience covering pharma’s patient access and affordability space via his time with Pharmaceutical Commerce.
Fully automated PA. Adaptive ROI support. EHR-integrated workflows that unify both medical and pharmacy benefits in a single platform. What will we build next? Find out at AXS26. Use this form to request a meeting — we’re already looking forward to seeing you there.
